Clover Health Investments (CLOV) Receivables - Other (2021 - 2024)

Clover Health Investments has reported Receivables - Other for 4 years, with the latest figure at $15.0 million in Q3 2024.

• For the quarter ending Q3 2024, Receivables - Other rose 1.37% year-over-year to $15.0 million; the trailing twelve-month figure through Sep 2024 stood at $15.0 million (up 1.37% YoY), and the FY2023 full-year result was $16.7 million, up 3233.2% from the prior year.
• Receivables - Other for Q3 2024 stood at $15.0 million, down from $21.2 million in the prior quarter.
• The five-year high for Receivables - Other was $24.3 million in Q1 2023, with the low at $500000.0 in Q4 2022.
• Historically, Receivables - Other has averaged $17.4 million across 4 years, with a median of $16.7 million in 2023.
• Annual changes were most pronounced in 2022 — Receivables - Other tumbled 96.5% — and 2023, when it soared 3233.2%.
• Clover Health Investments' Receivables - Other stood at $14.3 million in 2021, then plunged by 96.5% to $500000.0 in 2022, then soared by 3233.2% to $16.7 million in 2023, then fell by 10.22% to $15.0 million in 2024.
• The last three Receivables - Other figures came in at $15.0 million (Q3 2024), $21.2 million (Q2 2024), and $22.5 million (Q1 2024), per Business Quant data.